Predictive model of blood-brain barrier penetration of organic compounds

被引:187
作者
Ma, XL [1 ]
Chen, C [1 ]
Yang, J [1 ]
机构
[1] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Peoples R China
关键词
blood-brain barrier; quantitative structure-activity relationship; theoretical models;
D O I
10.1111/j.1745-7254.2005.00068.x
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Aim: To build up a theoretical model of organic compounds for the prediction of the activity of small molecules through the blood-brain barrier (BBB) in drug design. Methods: A training set of 37 structurally diverse compounds was used to construct quantitative structure-activity relationship (QSAR) models. Intermolecular and intramolecular solute descriptors were calculated using molecular mechanics, molecular dynamics simulations, quantum chemistry and so on. The QSAR models were optimized using multidimensional linear regression fitting and stepwise method. A test set of 8 compounds was, evaluated using the models as part of a validation process. Results: Significant QSAR models (R=0.955, s=0.232) of the BBB penetration of organic compounds were constructed. BBB penetration was found to depend upon the polar surface area, the octanol/water partition coefficient, Balaban Index, the strength of a small molecule to combine with the membrane-water complex, and the changeability of the structure of a solute-membrane-water complex. Conclusion: The QSAR models indicate that the distribution of organic molecules through BBB is not only influenced by organic solutes themselves, but also relates to the proper-ties of the solute-membrane-water complex, that is, interactions of the molecule with the phospholipid-rich regions of cellular membranes.
引用
收藏
页码:500 / 512
页数:13
相关论文
共 33 条
[1]  
Abraham M H, 1995, Drug Des Discov, V13, P123
[2]   On the partition of ampholytes: Application to blood-brain distribution [J].
Abraham, MH ;
TakacsNovak, K ;
Mitchell, RC .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 86 (03) :310-315
[3]   HYDROGEN-BONDING .33. FACTORS THAT INFLUENCE THE DISTRIBUTION OF SOLUTES BETWEEN BLOOD AND BRAIN [J].
ABRAHAM, MH ;
CHADHA, HS ;
MITCHELL, RC .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1994, 83 (09) :1257-1268
[4]  
*ACC INC, 2001, MAT STUD SAN DIEG US
[5]   Prodrugs for improved CNS delivery [J].
Anderson, BD .
ADVANCED DRUG DELIVERY REVIEWS, 1996, 19 (02) :171-202
[7]   Delivery of peptides and proteins through the blood-brain barrier (Reprinted from Advanced Drug Delivery Reviews, vol 10, pg 205-245, 1993) [J].
Bickel, U ;
Yoshikawa, T ;
Pardridge, WM .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 46 (1-3) :247-279
[8]  
*CAMBR INC, 2002, CHEM 2002 CS CHEM3D
[9]   Selective boron drug delivery to brain tumors for boron neutron capture therapy [J].
Chen, W ;
Mehta, SC ;
Lu, DR .
ADVANCED DRUG DELIVERY REVIEWS, 1997, 26 (2-3) :231-247
[10]   Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood-brain barrier penetration [J].
Clark, DE .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1999, 88 (08) :815-821